EMD
Click for more information
7.69% 5.6¢ emyria limited

Ann: EMD-RX5 Dosing to Complete for Phase 1 Clinical Trial
  1. ASX News
    lightbulb Created with Sketch. 851
    clock Created with Sketch.
    14/04/22
    10:07
    Post #: 60848576
    Likes Created with Sketch. 16  Upvote
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

A1M Swagman shoot proves plentiful for AIC, with Cu beyond 3% close to Eloise
right-arrow Created with Sketch.
EMD Emyria and UWA secure $499,411 grant to advance MDMA analogue drug program
right-arrow Created with Sketch.
AHK Ark Mines defines significant exploration target at Sandy Mitchell rare earths project
right-arrow Created with Sketch.
EX1 Tryptamine Therapeutics completes maiden dosing of IV psilocin – a global first
right-arrow Created with Sketch.
NEWS Has uranium run out of steam? An update on nuclear markets & developments ahead in FY25
right-arrow Created with Sketch.
AVA Ava Risk Group expands US presence with A$0.7M Substation Deal
right-arrow Created with Sketch.
watchlist Created with Sketch. Add EMD (ASX) to my watchlist
(20min delay)
Last
5.6¢ 		Change
0.004(7.69%) 		Mkt cap ! $22.90M
Open High Low Value Volume
5.5¢ 5.6¢ 5.5¢ $4.054K 73.26K

Buyers (Bids)

No. Vol. Price($)
1 15000 5.4¢
 

Sellers (Offers)

Price($) Vol. No.
5.6¢ 49998 1
View Market Depth
Last trade - 16.10pm 04/07/2024 (20 minute delay) ?
EMD (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.